ClinicalTrials.Veeva

Menu

CP382 - Intermittent Catheter (IC) PRO Panel Plan (382 PRO Panel)

Coloplast logo

Coloplast

Status

Not yet enrolling

Conditions

Intermittent Catheterization

Treatments

Other: No Intervention: Observational Cohort

Study type

Observational

Funder types

Industry
Other

Identifiers

Details and patient eligibility

About

The aim is to create an electronic patient reported outcome (e-PRO) based registry, specifically for subjects using an intermittent catheter as their primary bladder emptying method.

Full description

The registry's objective is to allow for insights into the needs of people with intimate healthcare needs from the user's perspective and experience. The registry will provide valuable information from the participants' perspective on several issues including, but not limited to product use and satisfaction, frequency of urinary tract infections, and quality-of-life related to IC use. The registry will allow for a more user-centric approach when listening and responding to the needs and challenges of IC users.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Willing to give informed consent
  • 18 years of age or above
  • Full legal capacity
  • Willing and able (self-assessed) to complete online questionnaires
  • using intermittent catheterization as the primary method for bladder emptying

Trial contacts and locations

0

Loading...

Central trial contact

Carri Browne. Clinical Project Manager, BS; Ann-Sophie luel-Brockdorff, Sr. Clinical Strategy Project Manager, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems